These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 17786534

  • 21. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M, Kimura A, Chiba Y, Yoshida Y.
    Thromb Haemost; 1988 Jun 16; 59(3):485-90. PubMed ID: 3142084
    [Abstract] [Full Text] [Related]

  • 22. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry.
    Sagheer S, Rodgers S, Yacoub O, Dauer R, Mcrae S, Duncan E.
    Haemophilia; 2016 May 16; 22(3):e200-7. PubMed ID: 27076201
    [Abstract] [Full Text] [Related]

  • 23. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 16; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 24. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM, Biguzzi E, Caiani V, Mistretta C, Bucciarelli P, Peyvandi F.
    Haemophilia; 2016 Jul 16; 22(4):564-9. PubMed ID: 26843468
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.
    Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U.
    J Thromb Haemost; 2008 Apr 16; 6(4):569-76. PubMed ID: 18208537
    [Abstract] [Full Text] [Related]

  • 26. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
    Goudemand J, Mazurier C, Marey A, Caron C, Coupez B, Mizon P, Goudemand M.
    Br J Haematol; 1992 Feb 16; 80(2):214-21. PubMed ID: 1550779
    [Abstract] [Full Text] [Related]

  • 27. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Feb 16; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 28. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C, Miesbach W.
    Acta Haematol; 2019 Feb 16; 142(2):71-78. PubMed ID: 31085919
    [Abstract] [Full Text] [Related]

  • 29. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL, Siekmann J, Schwarz HP.
    Semin Thromb Hemost; 2002 Apr 16; 28(2):149-60. PubMed ID: 11992238
    [Abstract] [Full Text] [Related]

  • 30. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
    Favaloro EJ, Mohammed S.
    Thromb Res; 2014 Dec 16; 134(6):1292-300. PubMed ID: 25300811
    [Abstract] [Full Text] [Related]

  • 31. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J.
    Thromb Haemost; 1999 Oct 16; 82(4):1276-82. PubMed ID: 10544913
    [Abstract] [Full Text] [Related]

  • 32. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR, Strasser EF, Ringwald J, Zimmermann R, Eckstein R.
    Clin Lab; 2012 Oct 16; 58(11-12):1203-9. PubMed ID: 23289190
    [Abstract] [Full Text] [Related]

  • 33. Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.
    Rydz N, Grabell J, Lillicrap D, James PD.
    Haemophilia; 2015 Sep 16; 21(5):636-41. PubMed ID: 25756206
    [Abstract] [Full Text] [Related]

  • 34. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
    Akin M, Karapinar DY, Balkan C, Ay Y, Kavakli K.
    Clin Appl Thromb Hemost; 2011 Oct 16; 17(5):441-8. PubMed ID: 20460340
    [Abstract] [Full Text] [Related]

  • 35. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep 16; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 36. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J.
    Haemophilia; 2011 Nov 16; 17(6):944-51. PubMed ID: 21371195
    [Abstract] [Full Text] [Related]

  • 37. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR, Rigsby P, Barrowcliffe TW.
    Thromb Haemost; 2001 Apr 16; 85(4):634-8. PubMed ID: 11341497
    [Abstract] [Full Text] [Related]

  • 38. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.
    Riddell AF, Jenkins PV, Nitu-Whalley IC, McCraw AH, Lee CA, Brown SA.
    Br J Haematol; 2002 Jan 16; 116(1):187-92. PubMed ID: 11841416
    [Abstract] [Full Text] [Related]

  • 39. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
    Penas N, Pérez-Rodríguez A, Torea JH, Lourés E, Noya MS, López-Fernández MF, Batlle J.
    Am J Hematol; 2005 Nov 16; 80(3):188-96. PubMed ID: 16247740
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ, Mohammed S.
    Thromb Res; 2016 May 16; 141():202-11. PubMed ID: 26743192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.